<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pntd.0006919.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pntd.0006919.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>CHIKF vaccines in late preclinical or clinical development.</title>
 </caption>
 <alternatives>
  <graphic id="pntd.0006919.t001g" xlink:href="pntd.0006919.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Vaccine name</th>
     <th align="left" rowspan="1" colspan="1">Developer</th>
     <th align="left" rowspan="1" colspan="1">Vaccine type</th>
     <th align="left" rowspan="1" colspan="1">Doses required/tested</th>
     <th align="left" rowspan="1" colspan="1">Current stage of testing (clinicaltrials.gov identifier)</th>
     <th align="left" rowspan="1" colspan="1">References</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">TSI-GSD-218 (181/clone25)</td>
     <td align="left" rowspan="1" colspan="1">United States Army Medical Research Institute of Infectious Diseases, University of Maryland</td>
     <td align="left" rowspan="1" colspan="1">Live-attenuated CHIKV strain</td>
     <td align="left" rowspan="1" colspan="1">1</td>
     <td align="left" rowspan="1" colspan="1">Completed Phase 2</td>
     <td align="left" rowspan="1" colspan="1">[
      <xref rid="pntd.0006919.ref032" ref-type="bibr">32</xref>, 
      <xref rid="pntd.0006919.ref033" ref-type="bibr">33</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">VRC-CHKVLP059-00-VP (PXVX0317 CHIKV-VLP)</td>
     <td align="left" rowspan="1" colspan="1">US National Institutes of Health, PaxVax</td>
     <td align="left" rowspan="1" colspan="1">Virus-like particle assembled from CHIKV proteins expressed in mammalian cells</td>
     <td align="left" rowspan="1" colspan="1">2</td>
     <td align="left" rowspan="1" colspan="1">Phase 2 (NCT02562482, NCT01489358, NCT03483961)</td>
     <td align="left" rowspan="1" colspan="1">[
      <xref rid="pntd.0006919.ref049" ref-type="bibr">49</xref>, 
      <xref rid="pntd.0006919.ref050" ref-type="bibr">50</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">MV-CHIK</td>
     <td align="left" rowspan="1" colspan="1">Inst. Pasteur, Themis Bioscience</td>
     <td align="left" rowspan="1" colspan="1">Recombinant live- attenuated measles vaccine expressing CHIKV virus-like particles derived from the structural protein genes</td>
     <td align="left" rowspan="1" colspan="1">2</td>
     <td align="left" rowspan="1" colspan="1">Phase 2 (NCT03101111, NCT02861586)</td>
     <td align="left" rowspan="1" colspan="1">[
      <xref rid="pntd.0006919.ref044" ref-type="bibr">44</xref>, 
      <xref rid="pntd.0006919.ref063" ref-type="bibr">63</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">VLA1553</td>
     <td align="left" rowspan="1" colspan="1">Valneva, Austria
      <break/>
     </td>
     <td align="left" rowspan="1" colspan="1">Recombinant CHIKV with nsP3 deletion</td>
     <td align="left" rowspan="1" colspan="1">1</td>
     <td align="left" rowspan="1" colspan="1">Recruiting for Phase 1 (NCT03382964)</td>
     <td align="left" rowspan="1" colspan="1">[
      <xref rid="pntd.0006919.ref038" ref-type="bibr">38</xref>, 
      <xref rid="pntd.0006919.ref064" ref-type="bibr">64</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">VAL-181388</td>
     <td align="left" rowspan="1" colspan="1">Moderna Therapeutics
      <break/>
     </td>
     <td align="left" rowspan="1" colspan="1">mRNA encoding the CHIKV structural proteins</td>
     <td align="left" rowspan="1" colspan="1">Not reported</td>
     <td align="left" rowspan="1" colspan="1">Recruiting for Phase 1 (NCT03325075)</td>
     <td align="left" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">pMCE321
      <break/>
     </td>
     <td align="left" rowspan="1" colspan="1">University of Pennsylvania, Philadelphia</td>
     <td align="left" rowspan="1" colspan="1">Structural protein genes E3, E2, and E1 linked in a single DNA construct with furin cleavage sites between them
      <break/>
     </td>
     <td align="left" rowspan="1" colspan="1">3</td>
     <td align="left" rowspan="1" colspan="1">Late preclinical (immunogenicity and efficacy in mice, immunogenicity in NHPs)</td>
     <td align="left" rowspan="1" colspan="1">[
      <xref rid="pntd.0006919.ref058" ref-type="bibr">58</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">CHIKV/IRES</td>
     <td align="left" rowspan="1" colspan="1">University of Texas Medical Branch, Takeda Pharmaceuticals</td>
     <td align="left" rowspan="1" colspan="1">Recombinant CHIKV with subgenomic promoter replaced by internal ribosome entry site to down-regulate structural proteins and prevent mosquito infection</td>
     <td align="left" rowspan="1" colspan="1">1</td>
     <td align="left" rowspan="1" colspan="1">Late preclinical (immunogenicity and efficacy in mice, NHPs)</td>
     <td align="left" rowspan="1" colspan="1">[
      <xref rid="pntd.0006919.ref041" ref-type="bibr">41</xref>â€“
      <xref rid="pntd.0006919.ref043" ref-type="bibr">43</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">EILV/CHIKV</td>
     <td align="left" rowspan="1" colspan="1">University of Texas Medical Branch</td>
     <td align="left" rowspan="1" colspan="1">Recombinant Eilat/chikungunya chimeric virus that is replication-defective in vertebrate cells</td>
     <td align="left" rowspan="1" colspan="1">1</td>
     <td align="left" rowspan="1" colspan="1">Late preclinical (immunogenicity and efficacy in mice, NHPs)</td>
     <td align="left" rowspan="1" colspan="1">[
      <xref rid="pntd.0006919.ref048" ref-type="bibr">48</xref>]
     </td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>
    <bold>Abbreviations:</bold> CHIKF, chikungunya fever; CHIKV, chikungunya virus; EILV, Eilat virus; NHP, nonhuman primate; nsP3, nonstructural protein 3.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
